E-mail

E-mail a Wiley Online Library Link

Takahiro Koyanagi, Yasuhiro Suzuki, Yasushi Saga, Shizuo Machida, Yuji Takei, Hiroyuki Fujiwara, Mitsuaki Suzuki and Yasufumi Sato In vivo delivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer Cancer Science 104

Version of Record online: 8 NOV 2013 | DOI: 10.1111/cas.12297

Thumbnail image of graphical abstract

Administration of siRNA targeting a novel angiogenesis stimulator, vasohibin-2, with atelocollagen biomaterial retarded ovarian tumor growth through decrease of angiogenesis and acceleration of vascular normalization. These results demonstrated the effectiveness of molecular targeting of vasohibin-2 in ovarian cancer.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH